Litcius/Paper detail

Inhaled Edoxaban dry powder inhaler formulations: Development, characterization and their effects on the coagulopathy associated with COVID-19 infection

Md Abdur Rashid, Saiqa Muneer, Jayanti Mendhi, Mohammad Zaidur Rahman Sabuj, Yahya Alhamhoom, Yin Xiao, Tony Wang, Emad L. Izake, Nazrul Islam

2021International Journal of Pharmaceutics20 citationsDOIOpen Access PDF

Topics & Concepts

AerosolizationDry-powder inhalerMagnesium stearateExcipientPharmacologyDifferential scanning calorimetryMedicineThermogravimetric analysisEdoxabanInhalerChromatographyParticle sizeInhalationChemistryDosage formAnesthesiaOrganic chemistryInternal medicineRivaroxabanWarfarinThermodynamicsAtrial fibrillationAsthmaPhysicsPhysical chemistryInhalation and Respiratory Drug DeliveryInfection Control and VentilationChronic Obstructive Pulmonary Disease (COPD) Research
Inhaled Edoxaban dry powder inhaler formulations: Development, characterization and their effects on the coagulopathy associated with COVID-19 infection | Litcius